Kronos Bio Inc (KRON) — Financial Flexibility Index

Latest as of March 2025: -0.45x

Kronos Bio Inc (KRON) has a Financial Flexibility Index of -0.45x as of March 2025. Free cash flow of $-12.84 Million (operating CF $-12.84 Million minus capex $4.00K) represents 0% of total liabilities ($28.33 Million). Check asset allocation strategy of Kronos Bio Inc to assess the company's strategic physical and investment asset allocation.

Financial Flexibility Index

-0.45x
Free Cash Flow / Total Liabilities

Free Cash Flow

$-12.84 Million
Operating CF − Capex

Total Liabilities

$28.33 Million
USD

Capital Expenditures

$4.00K
USD

Kronos Bio Inc Financial Flexibility Index (2018–2024)

Historical Financial Flexibility Index trend for Kronos Bio Inc across 7 annual periods. See how liquid is Kronos Bio Inc's working capital to evaluate short-term liquidity relative to the company's equity base.

Annual Financial Flexibility Index for Kronos Bio Inc (2018–2024)

Year-by-year free cash flow to debt coverage for Kronos Bio Inc. For the full company profile including market capitalisation, see KRON market cap overview.

Year Flexibility Index Free Cash Flow (USD) Operating CF Total Liabilities YoY Change
2024 -1.78x $-65.43 Million $-65.44 Million $36.78 Million ▼ -23.8%
2023 -1.44x $-77.90 Million $-78.58 Million $54.20 Million ▲ +19.8%
2022 -1.79x $-90.35 Million $-90.93 Million $50.44 Million ▲ +26.9%
2021 -2.45x $-113.66 Million $-117.92 Million $46.38 Million ▼ -301.6%
2020 -0.61x $-28.34 Million $-37.91 Million $46.45 Million ▼ -533.1%
2019 -0.10x $-12.13 Million $-15.08 Million $125.89 Million ▲ +64.2%
2018 -0.27x $-5.37 Million $-6.44 Million $19.91 Million
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities